On September 23, BlackRock's iShares Ethereum Trust (ETHA) attracted $50.8 million, nearly half of all US spot Ethereum ETF inflows that day, bringing cumulative inflows to over $13 billion. This highlights ETHA's dominance as the preferred institutional vehicle for Ethereum exposure, alongside BlackRock's staked Ethereum ETF (ETHB) which offers yield and has seen consistent inflows since its March 2026 launch. The growth of US spot Ethereum ETFs to $17 billion in net assets since mid-2024 reflects strong institutional demand for regulated, transparent, and easily accessible crypto investment options. This trend signals sustained momentum and growing acceptance of crypto ETFs in traditional investment portfolios.
BlackRock's Ethereum ETFs are the story subject, with Pluang market data offering context. As of Sep 24, 2026 12:02 WIB, 7 of 50 major cryptocurrencies rose and 42 fell on Pluang. Notable movers include CRV at Rp5.912 with a -8.06% change and 68% sell order activity, AXS at Rp18.643 with -7.77% change and 97% buy order activity, and SUSHI at Rp4.526 with -7.70% change and 53% sell order activity.
Wolters Kluwer repurchased 499 of its ordinary shares between October 29 and November 4, 2026, spending €0.04 million at an average price of €85.06 per share. This is part of a larger 2026 share buyback program aiming to repurchase shares worth up to...
Lorenz Snacks has introduced a fleet of four autonomous, electric vehicles from Einride at its production site in Neunburg vorm Wald, Germany. These vehicles will handle in-plant transport of goods and materials, replacing diesel trucks and significa...
Futu Holdings Limited will announce its financial results for the third quarter ending September 30, 2026, on November 19 before U.S. market open. The company will host a live earnings conference call at 7:30 AM ET (8:30 PM Beijing/Hong Kong time) th...
UBS Group AG notified Bang & Olufsen A/S that its shareholding and voting rights exceeded 5% as of October 30, 2026, but fell below 5% by November 2, 2026. As of November 2, UBS held 4.66% of Bang & Olufsen's total shares and voting rights. This chan...
T-Therapeutics secured $133 million in an oversubscribed Series B funding round led by Advent Life Sciences and British Business Bank to develop its first-in-class TCR-CD3 bispecific therapies targeting cancer and autoimmune diseases. The funds will ...
